Prime Medicine (PRME) Total Current Liabilities (2021 - 2026)

Prime Medicine's Total Current Liabilities history runs 6 years deep, the most recent figure standing at $36.3 million for Q1 2026.

• Quarterly Total Current Liabilities rose 5.84% year-over-year to $36.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $36.3 million (up 5.84% YoY) and the FY2025 annual result came in at $37.4 million, down 1.35% from the prior year.
• Total Current Liabilities was $36.3 million for Q1 2026 at Prime Medicine, down from $37.4 million in the prior quarter.
• Across five years, Total Current Liabilities topped out at $56.4 million in Q4 2023 and bottomed at $20.7 million in Q2 2024.
• A 5-year average of $33.0 million and a median of $34.3 million in 2025 frame the typical range for Total Current Liabilities.
• Annual changes were most pronounced in 2022 — Total Current Liabilities plunged 53.93% — and 2023, when it jumped 111.21%.
• Prime Medicine's Total Current Liabilities stood at $26.7 million in 2022, then soared by 111.21% to $56.4 million in 2023, then plunged by 32.72% to $38.0 million in 2024, then slipped by 1.35% to $37.4 million in 2025, then decreased by 3.09% to $36.3 million in 2026.
• Business Quant data shows PRME's Total Current Liabilities at $36.3 million in Q1 2026, $37.4 million in Q4 2025, and $35.0 million in Q3 2025.